William Blair Downgrades Neumora Therapeutics (NASDAQ:NMRA) to Market Perform
William Blair lowered shares of Neumora Therapeutics (NASDAQ:NMRA – Free Report) from an outperform rating to a market perform rating in a report released on Monday, Marketbeat Ratings reports. NMRA has been the subject of several other research reports. Royal Bank of Canada reissued a “sector perform” rating and set a $4.00 price objective on […]
William Blair lowered shares of Neumora Therapeutics (NASDAQ:NMRA – Free Report) from an outperform rating to a market perform rating in a report released on Monday, Marketbeat Ratings reports. NMRA has been the subject of several other research reports. Royal Bank of Canada reissued a “sector perform” rating and set a $4.00 price objective on […]
